Fulvestrant for the treatment of locally advanced or metastatic breast cancer. NICE technology appraisal guidance 239
National Institute for Health and Care Excellence (NICE)
Record ID 32018011190
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta239
Year Published:
2011
URL for published report:
https://www.nice.org.uk/guidance/ta239
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Breast Neoplasms
- Neoplasm Metastasis
- Fulvestrant
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents, Hormonal
- Estrogen Receptor Antagonists
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.